Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,194
Closed -$346K 86
2021
Q1
$346K Buy
3,194
+135
+4% +$14.4K 0.03% 83
2020
Q4
$328K Sell
3,059
-3,340
-52% -$321K 0.04% 77
2020
Q3
$560K Buy
6,399
+5,347
+508% +$503K 0.09% 78
2020
Q2
$103K Buy
1,052
+156
+17% +$13.7K 0.02% 124
2020
Q1
$68K Buy
896
+37
+4% +$3.15K 0.02% 125
2019
Q4
$76K Sell
859
-353
-29% -$29.3K 0.02% 129
2019
Q3
$92K Buy
1,212
+18
+2% +$1.23K 0.02% 243
2019
Q2
$87K Sell
1,194
-1,320
-53% -$104K 0.02% 248
2019
Q1
$203K Sell
2,514
-1,665
-40% -$136K 0.04% 197
2018
Q4
$385K Buy
4,179
+23
+0.6% +$2.02K 0.08% 126
2018
Q3
$393K Buy
4,156
+47
+1% +$4.46K 0.07% 153
2018
Q2
$381K Buy
4,109
+3,423
+499% +$334K 0.05% 147
2018
Q1
$7.25K Sell
686
-18,793
-96% -$2.06M 0.06% 117
2017
Q4
$1.88M Buy
19,479
+3,119
+19% +$294K 0.19% 43
2017
Q3
$1.45M Buy
16,360
+1,469
+10% +$112K 0.14% 59
2017
Q2
$1.08M Buy
14,891
+14,568
+4,510% +$979K 0.12% 71
2017
Q1
$4.96K Buy
323
+85
+36% +$5.34K 0.01% 80
2016
Q4
$3.8K Buy
+238
New +$14.5K 0.04% 55

Other funds holding ABBV

Sun Life Financial's ABBV Position: Q2 2021 in Review

Sun Life Financial sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 3,194 shares — an estimated $346K sold.

Sun Life Financial first reported a position in ABBV in Q4 2016 and held it in 18 quarters. The position peaked at $1.88M in Q4 2017. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Sun Life Financial reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
  • Sun Life Financial sold 3,194 AbbVie shares in Q2 2021, an estimated $346K.
  • Sun Life Financial first reported a position in AbbVie in Q4 2016 and held it in 18 quarters.
  • Sun Life Financial's AbbVie position peaked at $1.88M in Q4 2017.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Sun Life Financial's 13F filing for Q2 2021, filed 10 Aug 2021.